American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China’s National Insurance Catalog (redOrbit)

NEW YORK, Dec. 18 /PRNewswire-Asia-FirstCall/ — American Oriental Bioengineering, Inc.

This entry was posted in BioEngineering, Biotechnology. Bookmark the permalink.

Comments are closed.